Apria warned by FDA over oxygen supplies:
This article was originally published in Clinica
The FDA has warned US medical oxygen company Apria Healthcare that one of its filling facilities does not meet government standards. The filling plant in Tampa, Florida, was accused of having "no documentation or inconsistent evidence of the oxygen's identity, strength, quality and purity". The $1.1 billion company has 300 branches in the US and has been warned on previous occasions. The company says that patient safety had not been threatened.